| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/11/2002 | CN1368156A Nano medicine 'Huanyuan Gujing' and its preparing process |
| 09/11/2002 | CN1368151A Nano medicine 'Hailong Gejie' and its preparing process |
| 09/11/2002 | CN1368150A Nano medicine 'Haima Baji' and its preparing process |
| 09/11/2002 | CN1368147A Nano medicine 'Jianyang' and its preparing process |
| 09/11/2002 | CN1368145A Nano medicine 'Gengnianshu' and its preparing process |
| 09/11/2002 | CN1368142A Nano medicine 'Nukeshizhen' and its preparing process |
| 09/11/2002 | CN1368141A Nano medicine 'Miedi' and its preparing process |
| 09/11/2002 | CN1368123A Nano medicine 'Kanggongyan' and its preparing process |
| 09/11/2002 | CN1368118A Nano medicine 'Rujiling' and its preparing process |
| 09/11/2002 | CN1368114A Nano medicine 'Yajiaohadun' and its preparing process |
| 09/11/2002 | CN1368112A Nano medicine 'Yishenling' and its preparing process |
| 09/11/2002 | CN1368095A Nano medicine 'Lutai' and its preparing process |
| 09/11/2002 | CN1368084A Nano medicine 'Penyanjing' and its preparing process |
| 09/11/2002 | CN1368082A Nano medicine 'Qirong' and its preparing process |
| 09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
| 09/11/2002 | CN1090506C Application of lysozyme dimer |
| 09/11/2002 | CN1090504C Chinese medicine preparation for curing hyperplasia of mamary glands and its preparation method |
| 09/11/2002 | CN1090481C Estrogen/progestion-antiprogestin application its composition and medicine box |
| 09/10/2002 | USRE37838 Composition for contraception |
| 09/10/2002 | US6448397 Treating central nervous system diseases with modulation of 5-ht activity; adrenergic, dopaminergic, and serotonergic neurotransmitters; psychosis, paraphrenia, depression, mania, schizophrenia, anxiety, migraine headache, drug addiction |
| 09/10/2002 | US6448285 Disorders associated with overactivity of 5 alpha reductase; androgen dependent disorders such as seborrhoea, acne, hirsutism and/or androgenic alopecia |
| 09/10/2002 | US6448276 Such as 1-pyridin-3-yl-4-pyrrolidin-1-yl-but-1-ene; increasing hydration and lubrication of vaginal and cervical tissues; nicotine, epibatidine alkaloids and analogs |
| 09/10/2002 | US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 09/10/2002 | US6448267 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/10/2002 | US6448261 Arylamino fused pyridines |
| 09/10/2002 | US6448236 Functional agonists of the human adenosine a2a receptor and may be used as, for example, anti-inflammatory agents in the treatment of repiratory diseases |
| 09/10/2002 | US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes. |
| 09/10/2002 | US6447810 Sodium metasilicate, borax, sodium thiosulfate, potassium carbonate, refined sugar, water; improvement in disease resistance, weight gain rate, crop yield, crop quality, harvest time; antibody production and immune enhancement |
| 09/10/2002 | CA2198562C Method of treating conditions with estrogen agonists |
| 09/06/2002 | WO2002068548A1 Use of erss-selective ligands for regulating fertility and compounds useful therefore |
| 09/06/2002 | WO2002068463A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 09/06/2002 | WO2002068427A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 09/06/2002 | WO2002068419A1 Pyridopyrimidine or naphthyridine derivative |
| 09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2002 | WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 09/06/2002 | WO2002068397A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | WO2002068388A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002068387A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002067974A1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 09/06/2002 | WO2002067959A1 Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and prepairing process thereof |
| 09/06/2002 | WO2002067952A1 Prophylactic teat treatment |
| 09/06/2002 | WO2002067948A1 The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for preventing and treating sexual disorder |
| 09/06/2002 | WO2002067945A1 The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for treating cervical erosion |
| 09/06/2002 | WO2002067939A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | WO2002067919A1 Il-8 receptor antagonists |
| 09/06/2002 | WO2002067910A2 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
| 09/06/2002 | WO2002067873A2 Method for suppressing reduction of elasticity of skin |
| 09/06/2002 | WO2002067869A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002067851A2 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | WO2002043648A8 Compounds active at the glucocorticoid receptor ii |
| 09/06/2002 | WO2002038563A3 Condensed pyrazindione derivatives as pde inhibitors |
| 09/06/2002 | WO2002036792A3 Dna expression vectors |
| 09/06/2002 | WO2002036771A3 Imaging, diagnosis and treatment of disease |
| 09/06/2002 | WO2001012674A9 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 09/06/2002 | CA2439465A1 Prophylactic teat treatment |
| 09/06/2002 | CA2439463A1 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
| 09/06/2002 | CA2439265A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | CA2439119A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | CA2434727A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2433776A1 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
| 09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
| 09/05/2002 | US20020123529 Anti-arrhythmia, -ischemic, -proliferative and -diabetic agents; cardiotonic, necrosis; angina pectoris; peripheral and central nervous systems; protecting/preserving organs; inhibition of Na+/H+ exchange; diagnosis hypertonia |
| 09/05/2002 | US20020123513 Administering indole-2-carboxylic amide derivatives of given formula |
| 09/05/2002 | US20020123506 7-Heterocyclyl quinoline and thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 09/05/2002 | DE10109861A1 Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate Novel side-chain halogenated Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109859A1 Neuartige Aminodicarbonsäurederivate Novel Aminodicarbonsäurederivate |
| 09/05/2002 | DE10107663A1 Testosteronhaltiges transdermales therapeutisches System und Verfahren zu seiner Herstellung Testosterone-containing transdermal therapeutic system and process for its preparation |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236725A1 Novel 1,8-naphthyridin-2(1h)-one derivatives |
| 09/04/2002 | EP1235899A1 Treatment of human infertility |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235851A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 09/04/2002 | EP1235850A1 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds |
| 09/04/2002 | EP1235845A2 24 human secreted proteins |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235827A2 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 09/04/2002 | EP1235812A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 09/04/2002 | EP1235809A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 09/04/2002 | EP1235787A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 09/04/2002 | EP1235776A1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/04/2002 | EP1235579A1 Pharmaceutical compositions comprising trimegestone |
| 09/04/2002 | EP1054886B1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 09/04/2002 | EP0971690B1 Antiinfective free intramammary veterinary composition |
| 09/04/2002 | EP0760664B1 Use of pteridine derivatives as no-synthase inhibitors |
| 09/04/2002 | EP0755443B1 Tissue-specific enhancer active in prostate |
| 09/04/2002 | CN1367793A Neuromedin B and somatostatin receptor agonists |
| 09/04/2002 | CN1367792A Somatostatin agonists |
| 09/04/2002 | CN1367698A Administration of non-oral androgenic steroids to women |
| 09/04/2002 | CN1367696A Method of enhancing insulin action |
| 09/04/2002 | CN1367682A Drug delivery device, especially for delivery of androgens |
| 09/04/2002 | CN1367180A Novel natural antibacterial peptide, its code sequence and application |
| 09/04/2002 | CN1367169A Substituted 6,6-Hetero-dicycloderivative |
| 09/04/2002 | CN1367006A Maidangrutong and its preparation method |
| 09/04/2002 | CN1366996A Buyuwan pile |
| 09/04/2002 | CN1366961A Nano Duanxueliu preparation medicine and preparation method |
| 09/04/2002 | CN1366960A Nano Dingkun preparation medicine and preparation method |
| 09/04/2002 | CN1366959A Nano Tiaojing Cuyun preparation medicine and preparation method |
| 09/04/2002 | CN1366931A Nano deerhorn preparation medicine and preparation method |
| 09/04/2002 | CN1366923A Nano kindey-benefiting preparation medicine and preparation method |